ERASCA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.89 USD | +0.53% |
|
+5.59% | -11.27% |
| 04-03 | North American Morning Briefing : Powell Awaited -2- | DJ |
| 04-02 | Goldman Sachs Adjusts Erasca's Price Target to $7 From $6, Maintains Buy Rating | MT |
Chart calendar Erasca, Inc.
f9e904306a2ef7f.Dhg4tDfv27EbKHfPlPAqMBib3gSvOGnqWRIjMKzgEaA.eVRSw2-Hj4FBTAei25IaXHL6pGucVl-7ESFgRpqIQM5iemDNZ6G_30FvGA~4e3baccbfad6eba200db120949f7601a
Upcoming events on Erasca, Inc.
Past events on Erasca, Inc.
| 28/03/2024 12:30 | R&D Day |
| 27/03/2024 20:01 | Q4 2023 Earnings Release |
| 08/02/2024 16:00 | Guggenheim Healthcare Talks Biotechnology Conference |
| 09/01/2024 17:00 | JPMorgan Healthcare Conference |
| 28/11/2023 16:15 | Evercore ISI HealthCONx Conference |
| 15/11/2023 14:30 | Jefferies London Healthcare Conference |
| 09/11/2023 21:01 | Q3 2023 Earnings Release |
| 26/09/2023 13:10 | Cantor Global Healthcare Conference |
| 12/09/2023 22:30 | Morgan Stanley Global Healthcare Conference |
| 10/08/2023 21:01 | Q2 2023 Earnings Release |
| 22/06/2023 19:30 | Annual General Meeting |
| 12/06/2023 23:20 | Goldman Sachs Global Healthcare Conference |
| 07/06/2023 18:00 | Jefferies Healthcare Conference |
| 05/06/2023 21:30 | Business Update Call |
| 05/06/2023 21:30 | American Society of Clinical Oncology Conference |
| 05/06/2023 14:00 | American Society of Clinical Oncology Conference - Abstract 3557 |
| 05/06/2023 14:00 | American Society of Clinical Oncology Conference - Abstract 3558 |
| 15/05/2023 21:01 | Q1 2023 Earnings Release |
| 09/05/2023 22:20 | Bank of America Healthcare Conference |
| 18/04/2023 14:00 | American Association for Cancer Research Meeting - Abstract No CT184 |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -124 -129 4.06% | -245 -153 -59.96% | 0,00 -147 - | -165 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -125 -132 5.37% | -247 -152 -63% | -142 -147 3.97% | -156 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -123 -132 7.1% | -243 -145 -67.11% | -125 -127 1.5% | -136 |
|
Net income Million USD | Released Forecast Spread | -102 | -123 -133 7.41% | -243 -146 -66.87% | -125 -134 6.65% | -143 |
|
EPS USD | Released Forecast Spread | -4,84 | -1,85 -2,31 19.9% | -1,99 -1,32 -50.95% | -0,83 -0,93 10.6% | -0,89 |
| Announcement Date | 25/06/21 | 24/03/22 | 23/03/23 | 27/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | |
|
EBITDA Million USD | Released Forecast Spread | -30,7 -34,0 9.62% | -36,1 -36,0 -0.28% | -35,4 -39,3 9.99% | -36,2 -38,3 5.6% | -137 -37,1 -269.28% | |||||||||
|
EBIT Million USD | Released Forecast Spread | -31,0 -39,6 21.59% | -36,5 -35,3 -3.44% | -35,9 -38,0 5.59% | -37,0 -37,7 2.02% | -138 -43,4 -217.83% | -37,0 -45,5 18.7% | -36,0 -38,9 7.55% | -34,7 -38,2 9.24% | -33,9 -38,2 11.38% | -35,3 | -36,6 | -38,0 | -39,2 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -30,5 -39,5 22.88% | -36,5 -34,0 -7.23% | -35,6 -37,8 5.67% | -35,5 -37,8 5.99% | -135 -37,5 -260.67% | -33,2 -46,0 27.78% | -31,8 -35,1 9.54% | -30,4 -32,3 5.91% | -29,7 -30,9 3.97% | -30,5 | -32,2 | -33,7 | -35,5 | |
|
Net income Million USD | Released Forecast Spread | -30,5 -39,4 22.73% | -36,5 -35,1 -3.84% | -35,6 -38,2 6.73% | -35,5 -37,5 5.42% | -135 -37,5 -260.3% | -33,2 -46,0 27.78% | -31,8 -35,5 10.39% | -30,4 -32,3 5.91% | -29,7 -34,2 13.24% | -30,9 | -32,3 | -34,2 | -35,9 | |
|
EPS USD | Released Forecast Spread | -0,26 -0,37 28.88% | -0,31 -0,29 -5.5% | -0,30 -0,32 5.87% | -0,29 -0,31 6.45% | -1,06 -0,29 -270.49% | -0,22 -0,34 36.02% | -0,21 -0,23 10.02% | -0,20 -0,21 6.16% | -0,20 -0,23 11.32% | -0,20 | -0,21 | -0,23 | -0,22 | -0,25 |
| Announcement Date | 24/03/22 | 12/05/22 | 11/08/22 | 09/11/22 | 23/03/23 | 15/05/23 | 10/08/23 | 09/11/23 | 27/03/24 | - | - | - | - | - |
More events
Past sector events for Erasca, Inc.
| 26/04/2024 | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| 26/04/2024 | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 06:00 | BB BIOTECH AG: Q1 2024 Earnings Release |
| 25/04/2024 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 25/04/2024 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 25/04/2024 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 12:00 | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 25/04/2024 07:00 | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ERAS Stock
- Calendar Erasca, Inc.
